Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
25
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Lanvin Group Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Operational Hurdles And Brand Shifts Will Reshape Luxury Market Appeal
Key Takeaways Revenue decline due to saturated luxury markets and creative transitions may hinder revenue growth and market positioning. Operational inefficiencies and economic uncertainties could impact net margins and delay profitability, affecting earnings projections.
View narrative
US$1.50
FV
41.1% overvalued
intrinsic discount
10.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Healwell AI
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Healthcare Digitization Will Transform AI Software Services
Key Takeaways Refocusing on scalable AI software and strategic acquisitions positions Healwell to capitalize on global healthcare digitization, boosting margins, growth, and recurring revenues. Integration of advanced AI tools and active partnerships enhances customer retention, cross-selling, and operational efficiencies, supporting sustained value and industry leadership.
View narrative
CA$3.45
FV
59.7% undervalued
intrinsic discount
43.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
8 days ago
author updated this narrative
NeoGenomics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Advanced Oncology Diagnostics And NGS Capabilities Will Create Future Opportunities
Key Takeaways Launch of new liquid biopsy products and expanding test offerings position the company to capture market share and benefit from growth in oncology diagnostics demand. Investments in digital capabilities and strategic partnerships drive operational efficiency, support higher margins, and set up sustained earnings momentum.
View narrative
US$8.61
FV
23.3% undervalued
intrinsic discount
9.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
DouYu International Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Digital Monetization And Mobile Entertainment Will Unlock Value
Key Takeaways Diversification into innovative segments and digital monetization is strengthening revenue streams and reducing reliance on declining areas. Operational cost optimization and AI-driven efficiency initiatives are supporting margin improvement and earnings resilience.
View narrative
US$7.35
FV
12.6% overvalued
intrinsic discount
-4.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
8 days ago
author updated this narrative
Ampol
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
EG Australia And Z Energy Acquisitions Will Revitalize Fuel Network
Key Takeaways Expansion via acquisitions and alternative energy initiatives is set to boost Ampol's network scale, diversify earnings, and position it for evolving energy demand. Enhanced retail offerings, productivity gains, and industry consolidation support higher margins, customer loyalty, and stable long-term profitability.
View narrative
AU$32.94
FV
10.1% undervalued
intrinsic discount
0.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
44
users have followed this narrative
Updated
narrative
PNB Housing Finance
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
India's Urbanization And Branch Expansion Will Unlock New Momentum
Key Takeaways Expansion in affordable housing and tier 2/3/4 cities, along with rising urban demand, positions the company for strong long-term loan and revenue growth. Emphasis on digital processes, favorable regulations, and lower borrowing costs support operational efficiencies and profitability improvements.
View narrative
₹1.15k
FV
30.6% undervalued
intrinsic discount
15.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
2 days ago
author updated this narrative
fuboTV
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Streaming And Ad Tech Will Expand Future Markets
Key Takeaways Sports-focused bundles, exclusive content partnerships, and enhanced user personalization aim to drive subscriber growth, engagement, and revenue diversification. Improved ad technology, operational efficiency, and international expansion support margin gains and position for sustainable long-term profitability.
View narrative
US$4.50
FV
22.4% undervalued
intrinsic discount
3.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
39
users have followed this narrative
9 days ago
author updated this narrative
HLS Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Price Controls And Generics Will Erode Future Margins
Key Takeaways Upcoming patent expiries and growing generic competition threaten HLS's ability to sustain premium pricing, top-line sales, and long-term financial stability. Overreliance on a limited product range and lack of early-stage pipeline heighten the risk of volatile earnings and revenue contraction.
View narrative
CA$3.86
FV
35.2% overvalued
intrinsic discount
4.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
ModivCare
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Medicare Reimbursement Cuts And Digital Rivals Will Weaken Revenues
Key Takeaways Heavy reliance on government payers and traditional fee-for-service models exposes ModivCare to significant regulatory, reimbursement, and modernization risks, jeopardizing top-line growth and market viability. Digital disruption, operational inefficiencies, and balance sheet pressures undermine prospects for sustainable earnings improvement and raise concerns about long-term financial stability.
View narrative
US$1.20
FV
10.8% undervalued
intrinsic discount
0.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Value any company in seconds
Popular companies